Multidisciplinaire richtlijn Polyfarmacie bij ouderen

Monique Verduijn; Anne Leendertse; Annemarie Moeselaar; Niek De Wit; Rob Van Marum

doi:10.1007/s12445-013-0215-y

Multidisciplinaire richtlijn Polyfarmacie bij ouderen

Translated title of the contribution: Multidisciplinary guideline for polypharmacy in the elderly

Monique Verduijn^*, Anne Leendertse, Annemarie Moeselaar, Niek De Wit, Rob Van Marum

^*Corresponding author for this work

Research output: Contribution to journal › Article › Professional

Abstract

Older (> 65 years) patients who are being treated by different specialists for multiple medical problems are at increased risk of medication-related adverse effects. Unfortunately, little is known about the efficacy and safety of many medicines in these vulnerable patients. General practitioners can limit the risk of adverse effects by following the recommendations of the 'Polypharmacy for the Elderly' guideline and by using the START (Screening Tool to Alert doctors to Right Treatment) and STOPP (Screening Tool of Older Person's Prescriptions) criteria of the guideline. In addition, GPs can work with pharmacists to provide integrated pharmaceutical care by system atically evaluating the medicines prescribed using the stepwise approach of the STRIP (Systematic Tool to Reduce Inappropriate Prescribing). However, a number of preconditions for a good evaluation of medications have still to be met.

Translated title of the contribution	Multidisciplinary guideline for polypharmacy in the elderly
Original language	Dutch
Pages (from-to)	414-419
Number of pages	6
Journal	Huisarts en Wetenschap
Volume	56
Issue number	8
DOIs	https://doi.org/10.1007/s12445-013-0215-y
Publication status	Published - 1 Aug 2013

Access to Document

10.1007/s12445-013-0215-y

Cite this

@article{e760d70368ea4012a36a920f0c989c84,

title = "Multidisciplinaire richtlijn Polyfarmacie bij ouderen",

abstract = "Older (> 65 years) patients who are being treated by different specialists for multiple medical problems are at increased risk of medication-related adverse effects. Unfortunately, little is known about the efficacy and safety of many medicines in these vulnerable patients. General practitioners can limit the risk of adverse effects by following the recommendations of the 'Polypharmacy for the Elderly' guideline and by using the START (Screening Tool to Alert doctors to Right Treatment) and STOPP (Screening Tool of Older Person's Prescriptions) criteria of the guideline. In addition, GPs can work with pharmacists to provide integrated pharmaceutical care by system atically evaluating the medicines prescribed using the stepwise approach of the STRIP (Systematic Tool to Reduce Inappropriate Prescribing). However, a number of preconditions for a good evaluation of medications have still to be met.",

author = "Monique Verduijn and Anne Leendertse and Annemarie Moeselaar and {De Wit}, Niek and {Van Marum}, Rob",

year = "2013",

month = aug,

day = "1",

doi = "10.1007/s12445-013-0215-y",

language = "Dutch",

volume = "56",

pages = "414--419",

journal = "Huisarts en Wetenschap",

issn = "0018-7070",

publisher = "Bohn Stafleu van Loghum",

number = "8",

}

TY - JOUR

T1 - Multidisciplinaire richtlijn Polyfarmacie bij ouderen

AU - Verduijn, Monique

AU - Leendertse, Anne

AU - Moeselaar, Annemarie

AU - De Wit, Niek

AU - Van Marum, Rob

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Older (> 65 years) patients who are being treated by different specialists for multiple medical problems are at increased risk of medication-related adverse effects. Unfortunately, little is known about the efficacy and safety of many medicines in these vulnerable patients. General practitioners can limit the risk of adverse effects by following the recommendations of the 'Polypharmacy for the Elderly' guideline and by using the START (Screening Tool to Alert doctors to Right Treatment) and STOPP (Screening Tool of Older Person's Prescriptions) criteria of the guideline. In addition, GPs can work with pharmacists to provide integrated pharmaceutical care by system atically evaluating the medicines prescribed using the stepwise approach of the STRIP (Systematic Tool to Reduce Inappropriate Prescribing). However, a number of preconditions for a good evaluation of medications have still to be met.

AB - Older (> 65 years) patients who are being treated by different specialists for multiple medical problems are at increased risk of medication-related adverse effects. Unfortunately, little is known about the efficacy and safety of many medicines in these vulnerable patients. General practitioners can limit the risk of adverse effects by following the recommendations of the 'Polypharmacy for the Elderly' guideline and by using the START (Screening Tool to Alert doctors to Right Treatment) and STOPP (Screening Tool of Older Person's Prescriptions) criteria of the guideline. In addition, GPs can work with pharmacists to provide integrated pharmaceutical care by system atically evaluating the medicines prescribed using the stepwise approach of the STRIP (Systematic Tool to Reduce Inappropriate Prescribing). However, a number of preconditions for a good evaluation of medications have still to be met.

UR - http://www.scopus.com/inward/record.url?scp=84883288230&partnerID=8YFLogxK

U2 - 10.1007/s12445-013-0215-y

DO - 10.1007/s12445-013-0215-y

M3 - Article

AN - SCOPUS:84883288230

VL - 56

SP - 414

EP - 419

JO - Huisarts en Wetenschap

JF - Huisarts en Wetenschap

SN - 0018-7070

IS - 8

ER -

Multidisciplinaire richtlijn Polyfarmacie bij ouderen

Abstract

Access to Document

Other files and links

Cite this